Search Results

Display Settings
Results per page: 10
Sort By: Relevance
Filter
  • 1-10 of  4,565 results for ""Cohort Studies""

Your Filters

Subject : antineoplastic combined chemotherapy protocols Subject : carcinoma, hepatocellular Subject : liver neoplasms Filter by : Subject
Reset filters
Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request
Academic Journal

FOLFOX4 or sorafenib as the first-line treatments for advanced hepatocellular carcinoma: A cost-effectiveness analysis.

  • Authors : Zhang P; Department of Medical Oncology, Cancer Center, State Key Laboratory of Biotherapy, West China Hospital, Sichuan University, China; West China Biostatistics and Cost-Benefit Analysis Center, Sichuan University, China.

Subjects: Cost-Benefit Analysis*; Antineoplastic Combined Chemotherapy Protocols/Antineoplastic Combined Chemotherapy Protocols/Antineoplastic Combined Chemotherapy Protocols/*economics ; Carcinoma, Hepatocellular/Carcinoma, Hepatocellular/Carcinoma, Hepatocellular/*drug therapy Folfox protocol

  • Source: Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver [Dig Liver Dis] 2016 Dec; Vol. 48 (12), Publisher: Elsevier Country of Publication: Netherlands NLM ID: 100958385 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Read More Add to Saved list
×
Academic Journal

A genetic variant (rs17251221) in the calcium-sensing receptor relates to hepatocellular carcinoma susceptibility and clinical outcome treated by transcatheter hepatic arterial chemoembolization (TACE) therapy.

  • Authors : Tang Q; Department of Pharmacology, School of Pharmacy, China Medical University, Heping Ward, Shenyang City, 110001, Liaoning Province, People's Republic of China, .; Zhao Y

Subjects: Chemoembolization, Therapeutic*/Chemoembolization, Therapeutic*/Chemoembolization, Therapeutic*/methods; Antineoplastic Combined Chemotherapy Protocols/Antineoplastic Combined Chemotherapy Protocols/Antineoplastic Combined Chemotherapy Protocols/*administration & dosage ; Carcinoma, Hepatocellular/Carcinoma, Hepatocellular/Carcinoma, Hepatocellular/*genetics

  • Source: Medical oncology (Northwood, London, England) [Med Oncol] 2014 Nov; Vol. 31 (11), pp. 267. Date of Electronic Publication: 2014 Oct 01.Publisher: Springer Country of Publication: United States NLM ID: 9435512 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Read More Add to Saved list
×
Academic Journal

Modified cisplatin/interferon α-2b/doxorubicin/5-fluorouracil (PIAF) chemotherapy in patients with no hepatitis or cirrhosis is associated with improved response rate, resectability, and survival of initially unresectable hepatocellular carcinoma.

  • Authors : Kaseb AO; Department of Gastrointestinal Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.; Shindoh J

Subjects: Antineoplastic Combined Chemotherapy Protocols/Antineoplastic Combined Chemotherapy Protocols/Antineoplastic Combined Chemotherapy Protocols/*therapeutic use ; Carcinoma, Hepatocellular/Carcinoma, Hepatocellular/Carcinoma, Hepatocellular/*drug therapy ; Liver Neoplasms/Liver Neoplasms/Liver Neoplasms/*drug therapy

  • Source: Cancer [Cancer] 2013 Sep 15; Vol. 119 (18), pp. 3334-42. Date of Electronic Publication: 2013 Jul 02.Publisher: Wiley Country of Publication: United States NLM ID: 0374236 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1097-0142

Record details

Read More Add to Saved list
×
Academic Journal

Fibrolamellar variant of hepatocellular carcinoma does not have a better survival than conventional hepatocellular carcinoma--results and treatment recommendations from the Childhood Liver Tumour Strategy Group (SIOPEL) experience.

  • Authors : Weeda VB; Department of Paediatric Surgery, Emma Children's Hospital, AMC, Amsterdam, The Netherlands. ; Murawski M

Subjects: Antineoplastic Combined Chemotherapy Protocols/Antineoplastic Combined Chemotherapy Protocols/Antineoplastic Combined Chemotherapy Protocols/*therapeutic use ; Carcinoma, Hepatocellular/Carcinoma, Hepatocellular/Carcinoma, Hepatocellular/*drug therapy ; Liver/Liver/Liver/*drug effects Fibrolamellar hepatocellular carcinoma

  • Source: European journal of cancer (Oxford, England : 1990) [Eur J Cancer] 2013 Aug; Vol. 49 (12), pp. 2698-704. Date of Electronic Publication: 2013 May 15.Publisher: Elsevier Science Ltd Country of Publication: England NLM ID: 9005373 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Read More Add to Saved list
×
Academic Journal

Hepatic arterial infusion chemotherapy for advanced hepatocellular carcinoma according to Child-Pugh classification.

  • Authors : Miyaki D; Department of Medicine and Molecular Science, Division of Frontier Medical Science, Programs for Biomedical Research, Graduate School of Biomedical Sciences, Hiroshima University, Hiroshima, Japan.; Aikata H

Subjects: Hepatic Artery*; Antineoplastic Combined Chemotherapy Protocols/Antineoplastic Combined Chemotherapy Protocols/Antineoplastic Combined Chemotherapy Protocols/*therapeutic use ; Carcinoma, Hepatocellular/Carcinoma, Hepatocellular/Carcinoma, Hepatocellular/*classification

  • Source: Journal of gastroenterology and hepatology [J Gastroenterol Hepatol] 2012 Dec; Vol. 27 (12), pp. 1850-7.Publisher: Blackwell Scientific Publications Country of Publication: Australia NLM ID: 8607909 Publication Model: Print Cited Medium: Internet ISSN:

Record details

Read More Add to Saved list
×
Academic Journal

Systemic combination therapy of intravenous continuous 5-fluorouracil and subcutaneous pegylated interferon alfa-2a for advanced hepatocellular carcinoma.

  • Authors : Uchino K; Department of Gastroenterology, Graduate School of Medicine, The University of Tokyo, 7-3-1 Hongo, Bunkyo-ku, Tokyo 113-8655, Japan.; Obi S

Subjects: Antimetabolites, Antineoplastic/Antimetabolites, Antineoplastic/Antimetabolites, Antineoplastic/*therapeutic use ; Antineoplastic Combined Chemotherapy Protocols/Antineoplastic Combined Chemotherapy Protocols/Antineoplastic Combined Chemotherapy Protocols/*therapeutic use ; Antiviral Agents/Antiviral Agents/Antiviral Agents/*therapeutic use

  • Source: Journal of gastroenterology [J Gastroenterol] 2012 Oct; Vol. 47 (10), pp. 1152-9. Date of Electronic Publication: 2012 Mar 22.Publisher: Springer International Country of Publication: Japan NLM ID: 9430794 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Read More Add to Saved list
×
Academic Journal

PR-104 plus sorafenib in patients with advanced hepatocellular carcinoma.

  • Authors : Abou-Alfa GK; Memorial Sloan-Kettering Cancer Center, New York, NY 10065, USA. ; Chan SL

Subjects: Antineoplastic Combined Chemotherapy Protocols/Antineoplastic Combined Chemotherapy Protocols/Antineoplastic Combined Chemotherapy Protocols/*administration & dosage ; Antineoplastic Combined Chemotherapy Protocols/Antineoplastic Combined Chemotherapy Protocols/Antineoplastic Combined Chemotherapy Protocols/*adverse effects ; Benzenesulfonates/Benzenesulfonates/Benzenesulfonates/*adverse effects

  • Source: Cancer chemotherapy and pharmacology [Cancer Chemother Pharmacol] 2011 Aug; Vol. 68 (2), pp. 539-45. Date of Electronic Publication: 2011 May 19.Publisher: Springer Verlag Country of Publication: Germany NLM ID: 7806519 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Read More Add to Saved list
×
Academic Journal

A phase I/II study of combined chemotherapy with mitoxantrone and uracil/tegafur for advanced hepatocellular carcinoma.

  • Authors : Suzuki E; Department of Internal Medicine, Medical Oncology, Kyorin University School of Medicine, Tokyo 181-8611, Japan. ; Furuse J

Subjects: Antineoplastic Combined Chemotherapy Protocols/Antineoplastic Combined Chemotherapy Protocols/Antineoplastic Combined Chemotherapy Protocols/*therapeutic use ; Carcinoma, Hepatocellular/Carcinoma, Hepatocellular/Carcinoma, Hepatocellular/*drug therapy ; Liver Neoplasms/Liver Neoplasms/Liver Neoplasms/*drug therapy

  • Source: Japanese journal of clinical oncology [Jpn J Clin Oncol] 2011 Mar; Vol. 41 (3), pp. 328-33. Date of Electronic Publication: 2010 Nov 29.Publisher: Oxford University Press Country of Publication: England NLM ID: 0313225 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Read More Add to Saved list
×
Academic Journal

Pretreatment predictor of response, time to progression, and survival to intraarterial 5-fluorouracil/interferon combination therapy in patients with advanced hepatocellular carcinoma.

  • Authors : Uka K; Department of Medicine and Molecular Science, Division of Frontier Medical Science, Programs for Biomedical Research, Graduate School of Biomedical Sciences, Hiroshima University, 1-2-3 Kasumi, Hiroshima 734-8551, Japan.; Aikata H

Subjects: Antineoplastic Combined Chemotherapy Protocols/Antineoplastic Combined Chemotherapy Protocols/Antineoplastic Combined Chemotherapy Protocols/*therapeutic use ; Carcinoma, Hepatocellular/Carcinoma, Hepatocellular/Carcinoma, Hepatocellular/*drug therapy ; Hepatitis C Antibodies/Hepatitis C Antibodies/Hepatitis C Antibodies/*blood

  • Source: Journal of gastroenterology [J Gastroenterol] 2007 Oct; Vol. 42 (10), pp. 845-53. Date of Electronic Publication: 2007 Oct 15.Publisher: Springer International Country of Publication: Japan NLM ID: 9430794 Publication Model: Print-Electronic Cited Medium: Print ISSN:

Record details

Read More Add to Saved list
×
Academic Journal

The best candidates for transarterial chemotherapy in patients with hepatocellular carcinoma awaiting liver transplantation: a cohort-based characterization of dropout times.

  • Authors : Jang JW; Department of Internal Medicine, College of Medicine, WHO collaborating Center on Viral Hepatitis, The Catholic University of Korea, Seoul, Korea.; Choi JY

Subjects: Antineoplastic Combined Chemotherapy Protocols/Antineoplastic Combined Chemotherapy Protocols/Antineoplastic Combined Chemotherapy Protocols/*therapeutic use ; Carcinoma, Hepatocellular/Carcinoma, Hepatocellular/Carcinoma, Hepatocellular/*drug therapy ; Liver Neoplasms/Liver Neoplasms/Liver Neoplasms/*drug therapy

  • Source: Alimentary pharmacology & therapeutics [Aliment Pharmacol Ther] 2007 Jul 01; Vol. 26 (1), pp. 87-94.Publisher: Wiley-Blackwell Country of Publication: England NLM ID: 8707234 Publication Model: Print Cited Medium: Print ISSN: 0269-2813 (Print)

Record details

Read Online Read More Add to Saved list
×
  • 1-10 of  4,565 results for ""Cohort Studies""